Abstract
Children with open neural tube defects (NTDs) are prone to several endocrine problems. Short stature and precocious puberty are the most common endocrine sequelae of NTDs; however, abnormalities in thyroid hormone and prolactin (PRL) have also been reported. Thus, multidisciplinary evaluation and management of NTDs should also include a thorough endocrine evaluation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Charney EB, Rosenblum M, Finegold D (1981) Linear growth in a population of children with myelomeningocele. Z Kinderchir 34:415–491
Klauschie J, Rose SR (1996) Incidence of short stature in children with hydrocephalus. J Pediatr Endocrinol Metab 9:181–187
Rotenstein D, Adams M, Reigel DH (1995) Adult stature and anthropomorphic measurements of patients with myelomeningocele. Eur J Pediatr 154:398–402
Hoyt WF, Kaplan SL, Grumbach MM (1970) Septooptic dysplasia and pituitary dwarfism. Lancet 1:893–894
Rudman D, Duns T, Priest JH et al (1978) Prevalence of growth hormone deficiency in children with cleft lip or palate. J Pediatr 93:378–382
Wacharasindhu S, Asawutmangkul U, Srivuthana S (2005) Endocrine abnormalities in patients with fron — to ethmoidal encephalomeningocele. A pre limi nary study. Horm Res 64:64–67
Rotenstein D, Flom LL, Reigel DH (1989) Growth hormone treatment accelerates growth of short children with neural tube defects. J Pediatr 115:417–420
Rotenstein D (1990) Endocrine aspects of open neural tube defects. Neuroscience Journal 12:21–23
Lopponen T, Saukkonen AL, Serlo W et al (1997) Reduced levels of growth hormone, insulin-like growth factor-I and binding protein-3 in patients with shunted hydrocephalus. Arch Dis Child 77:32–37
Trollmann R, Strehl E, Wenzel D, Dorr HG (1998) Arm span, serum IGF-1 and IGFBP-3 levels as screening parameters for the diagnosis of growth hormone deficiency in patients with myelomeningocele-preliminary data. Eur J Pediatr 157:451–455
Satin-Smith MS, Katz LL, Thornton P et al (1996) Arm span as measurement of response to growth hormone (GH) treatment in a group of children with meningo — myelocele and GH deficiency. J Clin Endocrinol Metab 81:1654–1656
Hochhaus F, Butenandt O, Schwarz HP, Ring-Mrozik E (1997) Auxological and endocrinological evaluation of children with hydrocephalus and/or meningomyelocele. Eur J Pediatr 156:597–601
Lopponen T, Saukkonen AL, Serlo W et al (1995) Slow prepubertal linear growth but early pubertal growth spurt in patients with shunted hydrocephalus. Pediatrics 95:917–923
Perrone L, Del Gaizo D, D’Angelo E et al (1994) Endocrine studies in children with myelo me ningo cele. J Pediatr Endocrinol 7:219–23
Hochhaus F, Butenandt O, Ring-Mrozik E (1999) One-year treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: a comparison of supine length and arm span. J Pediatr Endocrinol Metab 12:153–159
Trollmann R, Bakker B, Lundberg M, Doerr HG (2006) Growth in pre-pubertal children with myelo — me ningocele (MMC) on growth hormone (GH): the KIGS experience. Pediatr Rehabil 9:144–148
Rotenstein D, Bass AN (2004) Treatment to near adult stature of patients with myelomeningocele with recombinant human growth hormone. J Pediatr Endocrinol Metab. 17:1195–1200
Rotenstein D, Reigel DH, Lucke JF (1996) Growth of growth hormone-treated and nontreated children before and after tethered spinal cord release. Pediatr Neurosurg 24:237–241
Furman L, Mortimer JC (1994) Menarche and menstrual function in patients with myelo meningo cele. Dev Medicine and Child Neurol 36:910–917
De Luca F, Muritano M, Rizzo G et al (1985) True precocious puberty: a long term complication in children with shunted non-tumoral hydrocephalus. Helvetica Paediatrica Acta 40:467–472
Meyer S, Landau H (1984) Precocious puberty in myelomeningocele patients. J Pediatr Orthop 4:28–31
Proos LA, Dahl M, Ahlsten G et al (1996) Increased perinatal intracranial pressure and prediction of early puberty in girls with myelomeningocele. Arch Dis Child 75:42–45
Kaplan S, Grumbach M (1990) Pathophysiology and treatment of sexual precocity. J Clin Endocrinol Metab 71:785–789
Trollmann R, Strehl E, Darr HG (1998) Precocious puberty in children with myelomeningocele: treatment with gonadotropin-releasing hormone analogues. Dev Med Child Neurol 40:38–43
Jackson AB, Sipski ML (2005) Reproductive issues for women with spina bifida. J Spinal Cord Med 28:81–91
Roberts D, Shepherd RW, Shepherd K (1991) Anthropometry and obesity in myelomeningocele. J Paediatr Child Health 27:83–90
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Italia
About this chapter
Cite this chapter
Bereket, A. (2008). Endocrine Aspects of Neural Tube Defects. In: The Spina Bifida. Springer, Milano. https://doi.org/10.1007/978-88-470-0651-5_34
Download citation
DOI: https://doi.org/10.1007/978-88-470-0651-5_34
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0650-8
Online ISBN: 978-88-470-0651-5
eBook Packages: MedicineMedicine (R0)